Anti-inflammatory Mechanism of Ruzu Bitters on Diet-Induced Nonalcoholic Fatty Liver Disease in Male Wistar Rats

Figure 2

Histological changes in different groups. VC: vascular congestion, CV: central vein, IPT: inflammatory portal tract, and ST: steatosis (magnification: ×100). (a) Control group. (b) Pioglitazone (4 mg/kg body weight). (c) Ruzu herbal bitters (0.6 mg/kg body weight). (d) NAFLD. (e) Fenofibrate (10 mg/kg body weight).

(a)

(b)

(c)

(d)

(e)